Kronox Lab Sciences reported a 16.9% increase in revenue to ₹28.39 crore and a 16.2% rise in profit after tax to ₹7.30 crore for Q1 FY27. The company focuses on specialty fine chemicals.
Kronox Lab Sciences Q1 FY27 Results
Kronox Lab Sciences reports Q1 FY27 revenue of ₹28.39 crore, up 16.9% YoY. Profit After Tax stands at ₹7.30 crore, a 16.2% increase YoY.
Reader Takeaway: Steady growth in specialty chemicals; AGM dividend declaration is key.
What just happened
Kronox Lab Sciences Limited announced its unaudited standalone financial results for the first quarter of the financial year ending June 30, 2026. The company reported revenue from operations of ₹28.39 crore and a profit after tax of ₹7.30 crore for the period.
This represents a year-over-year increase of 16.9% in revenue and 16.2% in profit after tax compared to the same quarter in the previous fiscal year.
Why this matters
The financial performance indicates continued growth for the company in its core business of manufacturing high-purity specialty fine chemicals. The steady rise in both top-line and bottom-line figures is a positive sign for shareholders, demonstrating operational efficiency and market demand.
The backstory
Kronox Lab Sciences operates in the specialty chemicals sector, focusing on high-purity products. The company's consistent performance reflects its strategic positioning within this niche market.
What changes now
The company has also scheduled its 17th Annual General Meeting (AGM) for September 16, 2026. During this meeting, a final dividend may be declared. The book closure for the AGM and dividend entitlement is from September 10 to September 16, 2026.
The re-appointment of M/s. Jaimin & Associates as Internal Auditors and the appointment of M/s. Diwanji & Associates as Cost Auditors for the fiscal year 2026-27 have also been approved.
Risks to watch
While the results are positive, investors should remain aware of the inherent risks in the specialty chemicals sector, including raw material price volatility and competition. Specific risks are not detailed in this filing.
Peer comparison
(Peer comparison data not available in the filing. The company operates in the specialty fine chemicals segment.)
Context metrics (time-bound)
- Revenue (Q1 FY27): ₹28.39 Crore
- Revenue (Q1 FY26): ₹24.29 Crore
- Profit After Tax (Q1 FY27): ₹7.30 Crore
- Profit After Tax (Q1 FY26): ₹6.28 Crore
What to track next
Investors should monitor the outcome of the AGM, particularly any dividend declaration, and the company's future performance updates as it continues to expand in the specialty chemicals market.
